Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5322 ARTÍCULOS , VIENDO DEL 2491 AL 2505

Mesenchymal stromal cell biotherapy for Parkinson's disease premotor symptoms

Sun J, Zhang W, Wei ZZ, Song X, Jian L, Jiang F, Wang S, Li H, Zhang Y, Tuo H; CtrLyin Group.

Chin Neurosurg J. 2023 Oct 13;9(1):28. doi: 10.1186/s41016-023-00338-z.

The Journal of Parkinson's Disease Takes the Open Road

Bloem BR, Kalia LV.

J Parkinsons Dis. 2023;13(1):1-2. doi: 10.3233/JPD-229011.

Efficacy of herbal medicine treatment based on syndrome differentiation for Parkinson's disease: A systematic review and meta-analysis of randomized placebo-controlled clinical trials

Jun P, Zhao H, Jung IC, Kwon O, Han CH, Won J, Jang JH.

Front Pharmacol. 2023 Feb 27;14:1108407. doi: 10.3389/fphar.2023.1108407. eCollection 2023.

Trichloroethylene: An Invisible Cause of Parkinson's Disease?

Dorsey ER, Zafar M, Lettenberger SE, Pawlik ME, Kinel D, Frissen M, Schneider RB, Kieburtz K, Tanner CM, De Miranda BR, Goldman SM, Bloem BR.

J Parkinsons Dis. 2023;13(2):203-218. doi: 10.3233/JPD-225047.

Role of epigenetic modifications in Parkinson's disease

Zhang JN, Li Q, Yang F.

Epigenomics. 2023 May;15(10):573-576. doi: 10.2217/epi-2023-0211. Epub 2023 Jul 11.

Editorial: Insights into Parkinson's disease and aging related movement disorders

Petersen RB, Walter B.

Front Aging Neurosci. 2023 May 17;15:1193197. doi: 10.3389/fnagi.2023.1193197. eCollection 2023.

People with Parkinson's as Partners for the Journal of Parkinson's Disease

McFarthing K, Bloem BR, Kalia LV.

J Parkinsons Dis. 2023;13(2):125-126. doi: 10.3233/JPD-239000.

Effects of Exercise-based Management on Motor Symptoms in Parkinson's Disease - A Meta-analysis

Hussain F, Farooqui S, Khan IA, Hassan B, Afridi ZK.

J Coll Physicians Surg Pak. 2023 Aug;33(8):919-926. doi: 10.29271/jcpsp.2023.08.919.

Editorial: Updates on inflammation in Parkinson's disease

Dzamko N, Romero-Ramos M, Thaler A.

Front Neurol. 2023 Jan 20;14:1138543. doi: 10.3389/fneur.2023.1138543. eCollection 2023.

GALC variants affect galactosylceramidase enzymatic activity and risk of Parkinson's disease

Senkevich K, Zorca CE, Dworkind A, Rudakou U, Somerville E, Yu E, Ermolaev A, Nikanorova D, Ahmad J, Ruskey JA, Asayesh F, Spiegelman D, Fahn S, Waters C, Monchi O, Dauvilliers Y, Dupré N, Greenbaum L, Hassin-Baer S, Grenn FP, Chiang MSR, Sardi SP, Vanderperre B, Blauwendraat C, Trempe JF, Fon EA, Durcan TM, Alcalay RN, Gan-Or Z.

Brain. 2023 May 2;146(5):1859-1872. doi: 10.1093/brain/awac413.

Wearable sensor-based gait analysis to discriminate early Parkinson's disease from essential tremor

Lin S, Gao C, Li H, Huang P, Ling Y, Chen Z, Ren K, Chen S.

J Neurol. 2023 Apr;270(4):2283-2301. doi: 10.1007/s00415-023-11577-6. Epub 2023 Feb 1.

Parkinson's disease pathology is directly correlated to SIRT3 in human subjects and animal models: Implications for AAV.SIRT3-myc as a disease-modifying therapy

Trinh D, Israwi AR, Brar H, Villafuerte JEA, Laylo R, Patel H, Jafri S, Al Halabi L, Sinnathurai S, Reehal K, Shi A, Gnanamanogaran V, Garabedian N, Pham I, Thrasher D, Monnier PP, Volpicelli-Daley LA, Nash JE.

Neurobiol Dis. 2023 Oct 15;187:106287. doi: 10.1016/j.nbd.2023.106287. Epub 2023 Sep 11.

Investigation of Shared Genetic Risk Factors Between Parkinson's Disease and Cancers

Sugier PE, Lucotte EA, Domenighetti C, Law MH, Iles MM, Brown K, Amos C, McKay JD, Hung RJ, Karimi M, Bacq-Daian D, Boland-Augé A, Olaso R, Deleuze JF, Lesueur F, Ostroumova E, Kesminiene A, de Vathaire F, Guénel P; EPITHYR consortium; Sreelatha AAK, Schulte C, Grover S, May P, Bobbili DR, Radivojkov-Blagojevic M, Lichtner P, Singleton AB, Hernandez DG, Edsall C, Mellick GD, Zimprich A, Pirker W, Rogaeva E, Lang AE, Koks S, Taba P, Lesage S, Brice A, Corvol JC, Chartier-Harlin MC, Mutez E, Brockmann K, Deutschländer AB, Hadjigeorgiou GM, Dardiotis E, Stefanis L, Simitsi AM, Valente EM, Petrucci S, Straniero L, Zecchinelli A, Pezzoli G, Brighina L, Ferrarese C, Annesi G, Quattrone A, Gagliardi M, Matsuo H, Nakayama A, Hattori N, Nishioka K, Chung SJ, Kim YJ, Kolber P, van de Warrenburg BPC, Bloem BR, Aasly J, Toft M, Pihlstrøm L, Guedes LC, Ferreira JJ, Bardien S, Carr J, Tolosa E, Ezquerra M, Pastor P, Diez-Fairen M, Wirdefeldt K, Pedersen N, Ran C, Belin AC, Puschmann A, Rödström EY, Clarke CE, Morrison KE, Tan M, Krainc D, Burbulla LF, Farrer MJ, Kruger R, Gasser T, Sharma M; Comprehensive Unbiased Risk Factor Assessment for Genetics and Environment in Parkinson's Disease (Courage-PD) consortium; Truong T, Elbaz A.

Mov Disord. 2023 Apr;38(4):604-615. doi: 10.1002/mds.29337. Epub 2023 Feb 14.

Multi-Modal Deep Learning Diagnosis of Parkinson's Disease-A Systematic Review

Skaramagkas V, Pentari A, Kefalopoulou Z, Tsiknakis M.

IEEE Trans Neural Syst Rehabil Eng. 2023;31:2399-2423. doi: 10.1109/TNSRE.2023.3277749. Epub 2023 May 25.

The Role of Sesamin in Targeting Neurodegenerative Disorders: A Systematic Review

Ghaderi MA, Emami SA, Beirak Olia MD, Javadi B.

Mini Rev Med Chem. 2023;23(6):756-770. doi: 10.2174/1389557522666220523112027.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias